Advocacy intelligence hub — real-time data for patient organizations
West China Hospital
Medical University of Warsaw — NA
Baylor College of Medicine — PHASE1
Zhongda Hospital
National Taiwan University Hospital — NA
Beijing Hospital — NA
Sotio Biotech Inc. — PHASE1, PHASE2
University of Colorado, Denver
Baylor College of Medicine — PHASE1
University Medical Center Groningen — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs2
Lipiodol
(ethiodized oil injection)Orphan drugGuerbet LLC
Radiographic Contrast Agent [EPC]
12.1 Mechanism of Action Lipiodol opacifies vessels and body structures in the path of the flow of the contrast medium, permitting visualization of th...
Nexavar
(sorafenib)Orphan drugBayer HealthCare Pharmaceuticals, Inc.
Kinase Inhibitor [EPC]
12.1 Mechanism of Action Sorafenib is a kinase inhibitor that decreases tumor cell proliferation in vitro. Sorafenib was shown to inhibit multiple int...
Tecentriq and Avastin
(atezolizumab + bevacizumab)Orphan drugstandardGenentech, Inc.
Pei Wang, PhD
Eureka Therapeutics Inc.
Gregory M Tiao, MD
Children's Oncology Group
📍 PALO ALTO, CA
Richard Kim
SWOG Cancer Research Network
AeRang Kim, MD, PhD, M.D
Children's National Research Institute
📍 BETHESDA, MD
Jessica Gartrell, MD, MD
St. Jude Children's Research Hospital
📍 MEMPHIS, TN
Allison O'Neill, MD
Dana-Farber Cancer Institute